On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation-Reference-Cited by-同舟云学术

On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation

Published:2002-05-19 Issue:3 Volume:117 Page:705-708
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gerotziafas Grigoris T.,Zervas Kostas,Arzoglou Pantelis,Karavaggeli Eli,Parashou Stella,Van Dreden Patrick,Christakis John,Samama Meyer Michel

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03437.x/fullpdf

Reference11 articles.

1. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage;Gerotziafas;American Journal of Hematology,2002

2. Phenotyping the clotting system;Hemker;Thrombosis and Haemostasis,2000

3. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high dose activated FVII;Hoffman;Blood Coagulation and Fibrinolysis,1998

4. High dose factor VIIa increases initial thrombin generation and mediates platelet activation in thrombocytopenia-like conditions in a cell-based model system;Kjalke;British Journal of Haematology,2001

5. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia;Kristensen;Haemostasis,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies;Thrombosis Research;2017-12

2. The various assays for measuring activity states of factor VIIa in plasma and therapeutic products: Diagnostic value and analytical usefulness in various pathophysiological states;Transfusion and Apheresis Science;2017-02

3. Alternatives to Allogeneic Transfusion;Mollison's Blood Transfusion in Clinical Medicine;2013-11-30

4. Intrapulmonary rFVIIa for life threatening pulmonary hemorrhage in a case of relapsing acute lymphoblastic leukemia and platelet refractoriness;Platelets;2013-10-08

5. Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study;BMC Neurology;2012-12